|
NUAK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65045754840776E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.32827124036339E-14 |
| Normal-vs-Stage2 |
5.42899059041702E-14 |
| Normal-vs-Stage3 |
1.63025148935958E-12 |
| Normal-vs-Stage4 |
1.64335212105016E-12 |
| Stage1-vs-Stage2 |
7.505000E-01 |
| Stage1-vs-Stage3 |
2.254100E-02 |
| Stage1-vs-Stage4 |
2.639000E-01 |
| Stage2-vs-Stage3 |
1.992350E-01 |
| Stage2-vs-Stage4 |
5.944200E-01 |
| Stage3-vs-Stage4 |
4.677200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64934732538313E-12 |
| Normal-vs-AfricanAmerican |
1.68365321684405E-12 |
| Normal-vs-Asian |
7.32747196252603E-15 |
| Caucasian-vs-AfricanAmerican |
6.929400E-01 |
| Caucasian-vs-Asian |
1.135240E-01 |
| AfricanAmerican-vs-Asian |
1.060180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63802305053196E-12 |
| Normal-vs-Female |
1.72528658026749E-12 |
| Male-vs-Female |
2.967700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.99840144432528E-15 |
| Normal-vs-Age(41-60Yrs) |
2.02060590481778E-14 |
| Normal-vs-Age(61-80Yrs) |
1.65889524339491E-12 |
| Normal-vs-Age(81-100Yrs) |
3.72309960638972E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.516500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.976600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.815800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.719600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.960400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.896800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.28029817250786E-11 |
| Normal-vs-Grade 2 |
1.68354219454159E-12 |
| Normal-vs-Grade 3 |
1.6654455592402E-12 |
| Normal-vs-Grade 4 |
1.62536650805123E-12 |
| Grade 1-vs-Grade 2 |
7.486800E-01 |
| Grade 1-vs-Grade 3 |
6.392600E-01 |
| Grade 1-vs-Grade 4 |
8.303800E-02 |
| Grade 2-vs-Grade 3 |
7.194800E-01 |
| Grade 2-vs-Grade 4 |
2.29379999999724E-05 |
| Grade 3-vs-Grade 4 |
1.035900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.79178893944254E-12 |
| Normal-vs-ccB subtype |
1.62636570877339E-12 |
| ccA subtype-vs-ccB subtype |
9.78770000048534E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65267799445701E-12 |
| Normal-vs-N1 |
4.55191440096314E-15 |
| N0-vs-N1 |
1.080190E-01 |
|
|
